Perspective: Research highlights at the Aaron Diamond AIDS Research Center: The β-chemokines, HIV type 1 second receptors, and exposed uninfected persons

AIDS Research and Human Retroviruses

Volumn 12, Issue 13, 1996, Pages 1203-1207

  Paxton, William A ^a   Dragic, Tatjana ^a   Koup, Richard A ^a   Moore, John P ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL FUSION; DISEASE RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INHIBITION; HUMAN; METABOLISM;

CHEMOKINES; HIV-1; HUMANS; RECEPTORS, VIRUS;

EID: 0030228507     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1203     Document Type: Review

References (51)

1. + T cells. Science 1995;270:1811-1815.
2. Paxton WA, Martin SR, Tse D, O'Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, and Koup RA: Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 1996;2:412-417.
3. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 1996;272:872-877.
4. + cells via the C-C CKR-5 co-receptor. Nature (London) 1996;381:667-673.
5. Moore JP, Jameson BA, Weiss RA, Sattentau QJ: The HIV-cell fusion reaction. In: Viral Fusion Mechanisms (Bentz J, ed.). CRC Press, Boca Raton, Florida, 1993, pp. 233-289.
6. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, and Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 1984;312:767-768.
7. Dalgleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 1984;312:763-766.
8. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, and Saxon A: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. N Engl J Med 1982;305:1425-1431.
9. + T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986;231:382-385.
10. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, and Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-348.
11. Ashorn PA, Berger EA, and Moss B: Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J Virol 1990;64:2149-2156.
12. Clapham PR, Blanc D. and Weiss RA: Specific cell surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian immunodeficiency virus. Virology 1991;181:703-715.
13. Simon JHM and James W: Heterokaryons formed between a rat myeloma and a mouse fibroblast are permissive for entry of HIV. AIDS Res Hum Retroviruses 1994;10:1609-1612.
14. Clapham PR, McKnight A, and Weiss RA: Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4. J Virol 1992;66:3531-3537.
15. Talbot SJ, Weiss RA, and Schulz TF: Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B). J Virol 1995;69:3399-3406.
16. Harouse JM, Bhat S, Spitalnik SL, Laughlin M, Stefano K, Silberberg DH, and Gonzalez-Scarano F: Inhibition of entry of HIV-1 into neural cell lines by antibodies against galactosyl ceramide. Science 1991;253:320-323.
17. Callebaut C, Krust B, Jacotot E, and Hovanessian AG: T cell activation antigen, CD26, as a cofactor for entry of HIV. Science 1993;262:2045-2050.
18. Broder CC, Nussbaum O, Gutheil WG, Bachovin WW, and Berger ES: CD26 and HIV fusion? Science 1994;264:1156-1159.
19. Patience C, McKnight A, Clapham PR, Boyd MT, Weiss RA, and Schulz TF: Science 1994;264:1159-1160.
20. Camerini D, Planelles V, and Chen ISY: Science 1994;264: 1160-1161.
21. Alizon M and Dragic T: Science 1994;264:1161-1162.
22. Stamatatos L and Levy J: CD26 is not involved in infection of peripheral blood mononuclear cells by HIV-1. AIDS 1994; 8:1727-1743.
23. Lazaro I, Naniche D, Signoret N, Bernard A-M, Marguet D, Klatzmann D, Drague T, Alizon M, and Sattentau Q: Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: Lack of evidence of a role for CD26. J Virol 1994;68:6535-6546.
24. Deng HK, Choe S, Ellmeier W, Liu R, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of C-C chemokine receptor 5 as the major coreceptor for entry of macrophage-tropic human immunodeficiency virus type 1. Nature (London) 1996;381: 661-666.
25. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, and Doms RW: A seven transmembrane domain receptor involved in fusion and entry of T-cell tropic human immunodeficiency virus type-1 strains. J Virol 1996 (in press).
26. Neote K, DiGregorio D, Mak JY, Horak R, and Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72:415-425.
27. Gao J-L, Kuhns DB, Tiffany HL, McDermott D, Li X, Francke U, and Murphy PM: Structure and functional expression of the human macrophage inflammatory protein 1a/RANTES receptor. J Exp Med 1993;177:1421-1427.
28. Bacon KB, Premack BA, Gardner P, and Schall TJ: Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995;269:1727-1729.
29. Raport CJ, Schweickart VL, Chantry D, Eddy Jr RL, Shoes TB, Godiska R, and Gray PW: New members of the chemokine receptor gene family. J Leuk Biol 1996;59:18-23.
30. Wells TNC, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung C-w, Peitsch MC, and Proudfoot AEI: Selectivity and antagonism of chemokine receptors. J Leuk Biol 1996;59:53-60.
31. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, and Moser B: Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994;269:232-237.
32. Walker CM, Moody DJ, Stites DP, and Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1988;234:1563-1566.
33. Cao Y, Qin L, Zhang L, Safrit J, and Ho DD: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-208.
34. + T cells. Immunol Today 1996;17:217-224.
35. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, and Coughlin SR: Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxy-terminal tails. Proc Natl Acad Sci USA 1994;91:2752-2756.
36. Ben-Baruch A, Xu L, Young PR, Bengali K, Oppenheim JJ, and Wang JM: Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1α/RANTES, is also a functional receptor for MCP3. J Biol Chem 1995;270:22123-22128.
37. Combadiere C, Ahuja SK, van Damme J, Tiffany HL, Gao J-L, and Murphy PM: Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 1995;270:29671-29675.
38. Harrowe G and Cheng-Mayer C: Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 1995;210:490-494.
39. Moore JP and Ho DD: HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells. AIDS 1995;9 (Suppl. A):S117-S136.
40. Litwin V, Nagashima K, Ryder AM, Chang C-H, Carver JM, Olson WC, Alizon M, Hassel KW, Maddon PJ, and Allaway GP: Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer. J Virol 1996;70 (in press).
41. + T-lymphocytes from two multiply exposed uninfected individuals resist infection with primary NSI isolates of human immunodeficiency virus-type 1. Submitted.
42. Combadiere C, Ahuja SK, and Murphy PM: Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995;270:16491-16494 (Correction, ibid p30235).
43. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M: Molecular cloning and functional expression of a new CC-chemokine receptor gene, CC-CKR5. Biochemistry 1996;11:3362-3367.
44. Chaudhuri A, Zbrzezna V, Polyakova J, Pogo AO, Hesselgesser J, and Horuk R: Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor. J Biol Chem 1994;269:7835-7838.
45. Neote K, Mak JY, Kolakowski LF Jr, and Schall TJ: Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor. Blood 1994;84:44-52.
46. Dragic T, Picard L, and Alizon M: Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1995;69:1013-1018.
47. Puri A, Morris SJ, Jones P, Ryan M, and Blumenthal R: Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins. Virology 1996;219:262-267.
48. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard G, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;86:1135-1148.
49. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper S, Parmentier M, Collman RG, and Doms RW: A dual-tropic, primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-2b as fusion cofactors. Cell 1996;86:1149-1159.
50. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CCCKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1, Science 1996;272:1955-1958.
51. Weiss RA and Clapham PR: Hot fusion of HIV. Nature (London) 1996;381:647-648.